Glaxosmithkline Pharmaceuticals Ltd

Glaxosmi. Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Glaxosmithkline Pharmaceuticals Ltd

₹ 2,390 0.04%
19 May 4:01 p.m.
gsk-india.com BSE: 500660 NSE: GLAXO
About

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)

Key Points

Leading Global Health care company[1] GlaxoSmithKline Pharmaceutical is a part of GlaxoSmithKline plc (GSK), a British multinational pharmaceutical company headquartered in London. GSK underwent a merger in 2000 of Glaxo Wellcome and SmithKline Beecham, and is the world’s sixth-largest pharmaceutical company.

Website BSE NSE
  • Market Cap ₹ 40,493 Cr.
  • Current Price ₹ 2,390
  • High / Low ₹ 3,516 / 2,218
  • Stock P/E 39.7
  • Book Value ₹ 134
  • Dividend Yield 2.39 %
  • ROCE 65.1 %
  • ROE 48.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 44.5%
  • Company has been maintaining a healthy dividend payout of 94.6%

Cons

  • Stock is trading at 17.8 times its book value
  • The company has delivered a poor sales growth of 5.49% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
787 762 957 805 930 815 1,011 949 974 805 980 1,041 995
618 618 668 587 673 584 689 658 641 554 644 670 644
Operating Profit 170 144 289 218 257 231 322 292 333 251 336 371 351
OPM % 22% 19% 30% 27% 28% 28% 32% 31% 34% 31% 34% 36% 35%
38 54 28 -135 32 36 39 35 41 44 36 50 36
Interest 1 0 0 0 1 0 0 0 1 0 1 1 1
Depreciation 17 16 18 17 18 16 17 19 15 16 17 20 13
Profit before tax 190 181 299 65 271 249 344 308 359 279 354 400 373
Tax % 30% 27% 27% 30% 28% 27% 27% 25% 27% 27% 27% 26% 26%
133 132 218 46 194 182 252 230 263 205 257 296 278
EPS in Rs 7.88 7.81 12.84 2.70 11.48 10.76 14.91 13.57 15.52 12.10 15.20 17.45 16.40
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 15m Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
3,305 2,838 2,908 2,871 3,128 3,224 2,926 3,278 3,252 3,454 3,749 3,822
2,672 2,360 2,489 2,363 2,527 2,567 2,327 2,516 2,447 2,545 2,570 2,512
Operating Profit 633 478 420 508 601 657 598 762 804 909 1,179 1,309
OPM % 19% 17% 14% 18% 19% 20% 20% 23% 25% 26% 31% 34%
149 125 119 70 131 -262 9 1,401 103 -21 149 166
Interest 0 0 0 0 1 6 4 2 2 2 1 3
Depreciation 25 25 27 38 49 83 79 68 66 70 67 66
Profit before tax 756 578 511 540 683 306 525 2,093 839 816 1,260 1,406
Tax % 37% 35% 34% 35% 35% 70% 32% 19% 27% 28% 26% 26%
476 376 337 351 445 93 358 1,695 611 590 928 1,036
EPS in Rs 28.12 22.20 19.88 20.70 26.29 5.50 21.14 100.04 36.05 34.83 54.75 61.15
Dividend Payout % 111% 113% 75% 85% 76% 727% 142% 90% 89% 92% 99% 93%
Compounded Sales Growth
10 Years: 3%
5 Years: 5%
3 Years: 6%
TTM: 2%
Compounded Profit Growth
10 Years: 11%
5 Years: 16%
3 Years: 20%
TTM: 17%
Stock Price CAGR
10 Years: 3%
5 Years: 10%
3 Years: 23%
1 Year: -15%
Return on Equity
10 Years: 33%
5 Years: 48%
3 Years: 45%
Last Year: 48%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 85 85 85 85 169 169 169 169 169 169 169 169
Reserves 1,744 2,099 1,922 1,973 1,970 1,651 1,309 2,494 1,572 1,608 1,782 2,098
3 2 2 1 1 0 35 20 16 19 10 33
1,384 869 995 1,889 1,771 1,315 1,602 1,950 1,570 1,760 2,147 2,023
Total Liabilities 3,216 3,055 3,004 3,947 3,911 3,136 3,115 4,633 3,327 3,557 4,108 4,324
123 204 258 325 432 758 387 331 330 321 284 281
CWIP 115 268 605 923 1,003 120 13 30 20 14 14 33
Investments 0 6 0 0 0 0 0 366 518 813 1,118 1,392
2,977 2,577 2,140 2,700 2,477 2,257 2,715 3,907 2,458 2,408 2,692 2,618
Total Assets 3,216 3,055 3,004 3,947 3,911 3,136 3,115 4,633 3,327 3,557 4,108 4,324

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
338 139 234 473 409 490 578 811 484 582 1,290 903
180 499 301 -104 -153 -57 418 -406 808 9 -46 397
-497 -638 -511 -307 -358 -428 -696 -524 -1,543 -562 -769 -737
Net Cash Flow 21 -0 24 62 -102 6 300 -119 -251 29 475 563
Free Cash Flow 175 -69 -24 639 166 336 536 2,371 451 573 1,273 849
CFO/OP 93% 72% 94% 133% 101% 103% 121% 122% 93% 92% 116% 93%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 11 16 21 19 14 11 27 23 22 23 28 26
Inventory Days 91 156 111 147 131 135 159 144 131 144 126 124
Days Payable 74 97 73 149 109 100 135 156 122 171 186 154
Cash Conversion Cycle 27 75 60 17 36 46 50 11 31 -4 -31 -4
Working Capital Days -48 26 7 -90 -72 -38 -39 -94 -57 -64 -99 42
ROCE % 42% 29% 22% 26% 31% 33% 38% 37% 36% 51% 63% 65%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Employees
Count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Packs Distributed Annually
Million Packs ・Standalone data
Manufacturing Capacity (Nashik Plant Tablets)
Billion Tablets ・Standalone data
Market Share of Key Promoted Brands
% ・Standalone data
Overall Industry Ranking (by value)
Rank ・Standalone data
Daily Unit Doses Distributed
Billion Unit Doses ・Standalone data
Number of Contract Manufacturing Units (CMOs)
Count ・Standalone data
Unique Healthcare Professionals (HCP) Reach
Count ・Standalone data
Number of Medical Representatives (Sales Force)
Count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
2.41% 2.50% 2.93% 3.48% 4.02% 4.36% 4.50% 4.52% 4.89% 4.79% 4.63% 4.62%
10.25% 10.01% 8.64% 7.90% 7.51% 7.34% 7.30% 7.79% 7.71% 7.75% 7.70% 7.68%
0.00% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
12.35% 12.48% 13.42% 13.62% 13.48% 13.30% 13.21% 12.69% 12.41% 12.45% 12.67% 12.69%
No. of Shareholders 1,19,0321,15,2681,14,6631,18,9941,18,5151,19,2281,19,6251,21,8851,23,6291,22,9041,22,4601,21,763

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls